Contact us for information regarding our sample policy
standard
Australia North America Eastern Europe Middle East Africa Central America South America Asia
All India
depend
Product Description
Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia).